A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

Tae-Won Kim,Anneli Elme,Zvonko Kusić,Joon Oh Park,Anghel Adrian Udrea,Sunyoung Kim,Joong Bae Ahn,Ricardo Villalobos Valencia,Srinivasan Krishnan,Ante Bilic,Nebojsa Manojlovic,Jun Dong,Xuesong Guan,Catherine Lofton-Day,A. Scott Jung,Eduard Vrdoljak

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

2016

Tae-Won Kim
Anneli Elme
Zvonko Kusić
Joon Oh Park
Anghel Adrian Udrea
Sunyoung Kim
Joong Bae Ahn
Ricardo Villalobos Valencia
Srinivasan Krishnan
Ante Bilic
Nebojsa Manojlovic
Jun Dong
Xuesong Guan
Catherine Lofton-Day
A. Scott Jung
Eduard Vrdoljak

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

Keywords:

Breast cancer
Pathology
Immunology
Medicine
KRAS
Prostate cancer
Liver cancer
Colorectal cancer
Lung cancer
Panitumumab
Genetic enhancement
Skin cancer
Internal medicine
Cervical cancer
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations